Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 2
1951 1
1952 3
1953 2
1954 2
1955 2
1956 1
1957 1
1959 2
1960 3
1963 1
1964 1
1966 2
1967 4
1968 1
1969 4
1970 1
1971 1
1972 2
1973 2
1974 1
1975 2
1976 7
1977 3
1978 1
1979 3
1980 12
1981 5
1982 5
1983 6
1984 14
1985 9
1986 9
1987 10
1988 12
1989 9
1990 17
1991 19
1992 26
1993 23
1994 18
1995 24
1996 22
1997 34
1998 35
1999 52
2000 43
2001 32
2002 47
2003 45
2004 64
2005 62
2006 61
2007 33
2008 42
2009 48
2010 41
2011 53
2012 61
2013 62
2014 66
2015 67
2016 68
2017 68
2018 68
2019 55
2020 76
2021 84
2022 81
2023 66
2024 69
2025 35

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,770 results

Results by year

Filters applied: . Clear all
Page 1
Guideline for the management of myasthenic syndromes.
Wiendl H, Abicht A, Chan A, Della Marina A, Hagenacker T, Hekmat K, Hoffmann S, Hoffmann HS, Jander S, Keller C, Marx A, Melms A, Melzer N, Müller-Felber W, Pawlitzki M, Rückert JC, Schneider-Gold C, Schoser B, Schreiner B, Schroeter M, Schubert B, Sieb JP, Zimprich F, Meisel A. Wiendl H, et al. Among authors: keller c. Ther Adv Neurol Disord. 2023 Dec 26;16:17562864231213240. doi: 10.1177/17562864231213240. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 38152089 Free PMC article. Review.
Ravulizumab and Efgartigimod in Myasthenia Gravis: A Real-World Study.
Stascheit F, Sousa CDF, Aigner A, Behrens M, Keller CW, Klotz L, Lehnerer S, Stein M, Herdick M, Doksani P, Gerischer LM, Hoffmann S, Lazaridis K, Tzartos J, Wiendl H, Meisel A, Lünemann JD. Stascheit F, et al. Among authors: keller cw. Neurol Neuroimmunol Neuroinflamm. 2025 Jan;12(1):e200331. doi: 10.1212/NXI.0000000000200331. Epub 2024 Nov 27. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 39602677 Free PMC article.
Entinostat as a combinatorial therapeutic for rhabdomyosarcoma.
Chauhan S, Lian E, Habib I, Liu Q, Anders NM, Bugg MM, Federman NC, Reid JM, Stewart CF, Cates T, Michalek JE, Keller C. Chauhan S, et al. Among authors: keller c. Sci Rep. 2024 Aug 15;14(1):18936. doi: 10.1038/s41598-024-66545-5. Sci Rep. 2024. PMID: 39147820 Free PMC article.
Perimenopausal obesity.
Keller C, Larkey L, Distefano JK, Boehm-Smith E, Records K, Robillard A, Veres S, Al-Zadjali M, O'Brian AM. Keller C, et al. J Womens Health (Larchmt). 2010 May;19(5):987-96. doi: 10.1089/jwh.2009.1547. J Womens Health (Larchmt). 2010. PMID: 20380578
High-resolution transcriptomic and epigenetic profiling identifies novel regulators of COPD.
Schwartz U, Llamazares Prada M, Pohl ST, Richter M, Tamas R, Schuler M, Keller C, Mijosek V, Muley T, Schneider MA, Quast K, Hey J, Heußel CP, Warth A, Winter H, Serçin Ö, Karmouty-Quintana H, Jyothula SS, Patel MK, Herth F, Koch I, Petrosino G, Titimeaua A, Mardin BR, Weichenhan D, Jurkowski TP, Imbusch CD, Brors B, Benes V, Jung B, Wyatt D, Stahl HF, Plass C, Jurkowska RZ. Schwartz U, et al. Among authors: keller c. EMBO J. 2023 Jun 15;42(12):e111272. doi: 10.15252/embj.2022111272. Epub 2023 May 5. EMBO J. 2023. PMID: 37143403 Free PMC article.
Translational Aspects of Epithelioid Sarcoma: Current Consensus.
Grünewald TGP, Postel-Vinay S, Nakayama RT, Berlow NE, Bolzicco A, Cerullo V, Dermawan JK, Frezza AM, Italiano A, Jin JX, Le Loarer F, Martin-Broto J, Pecora A, Perez-Martinez A, Tam YB, Tirode F, Trama A, Pasquali S, Vescia M, Wortmann L, Wortmann M, Yoshida A, Webb K, Huang PH, Keller C, Antonescu CR. Grünewald TGP, et al. Among authors: keller c. Clin Cancer Res. 2024 Mar 15;30(6):1079-1092. doi: 10.1158/1078-0432.CCR-23-2174. Clin Cancer Res. 2024. PMID: 37916971 Free PMC article. Review.
A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastoma.
Espinoza AF, Patel RH, Patel KR, Badachhape AA, Whitlock R, Srivastava RK, Govindu SR, Duong A, Kona A, Kureti P, Armbruster B, Kats D, Srinivasan RR, Dobrolecki LE, Yu X, Najaf Panah MJ, Zorman B, Sarabia SF, Urbicain M, Major A, Bissig KD, Keller C, Lewis MT, Heczey A, Sumazin P, López-Terrada DH, Woodfield SE, Vasudevan SA. Espinoza AF, et al. Among authors: keller c. J Hepatol. 2024 Apr;80(4):610-621. doi: 10.1016/j.jhep.2024.01.003. Epub 2024 Jan 17. J Hepatol. 2024. PMID: 38242326
Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells.
Grevet JD, Lan X, Hamagami N, Edwards CR, Sankaranarayanan L, Ji X, Bhardwaj SK, Face CJ, Posocco DF, Abdulmalik O, Keller CA, Giardine B, Sidoli S, Garcia BA, Chou ST, Liebhaber SA, Hardison RC, Shi J, Blobel GA. Grevet JD, et al. Among authors: keller ca. Science. 2018 Jul 20;361(6399):285-290. doi: 10.1126/science.aao0932. Science. 2018. PMID: 30026227 Free PMC article.
1,770 results